Stephen A. Strickland, M.D.

Assistant Professor

stephen.strickland@vanderbilt.edu
Faculty Appointments
Assistant Professor of Medicine
Education
M.S.C.I., Clinical Investigation , Vanderbilt University, Nashville, TennesseeM.D., Louisiana State University School of Medicine, New Orleans, LouisianaB.S., Louisiana State University, Baton Rouge, Louisiana
Office Address
2220 Pierce Avenue
777 PRB
Nashville, TN 37232
Publications
Perl AE, Altman JK, Cortes J, Smith C, Litzow M, Baer MR, Claxton D, Erba HP, Gill S, Goldberg S, Jurcic JG, Larson RA, Liu C, Ritchie E, Schiller G, Spira AI, Strickland SA, Tibes R, Ustun C, Wang ES, Stuart R, Röllig C, Neubauer A, Martinelli G, Bahceci E, Levis M. Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1-2 study. Lancet Oncol [print-electronic]. 2017 Aug; 18(8): 1061-75. PMID: 28645776, PII: S1470-2045(17)30416-3, DOI: 10.1016/S1470-2045(17)30416-3, ISSN: 1474-5488.

Strickland SA, Sun Z, Ketterling RP, Cherry AM, Cripe LD, Dewald G, Fernandez HF, Hicks GA, Higgins RR, Lazarus HM, Litzow MR, Luger SM, Paietta EM, Rowe JM, Vance GH, Wiernik P, Wiktor AE, Zhang Y, Tallman MS, . Independent Prognostic Significance of Monosomy 17 and Impact of Karyotype Complexity in Monosomal Karyotype/Complex Karyotype Acute Myeloid Leukemia: Results from Four ECOG-ACRIN Prospective Therapeutic Trials. Leuk. Res [print-electronic]. 2017 May 5/12/2017; 59: 55-64. PMID: 28551161, PII: S0145-2126(17)30424-1, DOI: 10.1016/j.leukres.2017.05.010, ISSN: 1873-5835.

Guo Y, Strickland SA, Mohan S, Li S, Bosompem A, Vickers KC, Zhao S, Sheng Q, Kim AS. MicroRNAs and tRNA-derived fragments predict the transformation of myelodysplastic syndromes to acute myeloid leukemia. Leuk. Lymphoma [print-electronic]. 2017 Jan 1/13/2017; 1-15. PMID: 28084850, DOI: 10.1080/10428194.2016.1272680, ISSN: 1029-2403.

Jamieson GC, Fox JA, Poi M, Strickland SA. Molecular and Pharmacologic Properties of the Anticancer Quinolone Derivative Vosaroxin: A New Therapeutic Agent for Acute Myeloid Leukemia. Drugs. 2016 Sep; 76(13): 1245-55. PMID: 27484675, PMCID: PMC4989016, PII: 10.1007/s40265-016-0614-z, DOI: 10.1007/s40265-016-0614-z, ISSN: 1179-1950.

Zhao Y, Liu Q, Acharya P, Stengel KR, Sheng Q, Zhou X, Kwak H, Fischer MA, Bradner JE, Strickland SA, Mohan SR, Savona MR, Venters BJ, Zhou MM, Lis JT, Hiebert SW. High-Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML. Cell Rep [print-electronic]. 2016 Aug 8/16/2016; 16(7): 2003-16. PMID: 27498870, PMCID: PMC4996374, PII: S2211-1247(16)30950-0, DOI: 10.1016/j.celrep.2016.07.032, ISSN: 2211-1247.

Strickland SA, Mohan SR, Savona MR. Unfavorable-risk acute myeloid leukemia dissected. Curr. Opin. Hematol. 2016 Mar; 23(2): 144-9. PMID: 26825699, DOI: 10.1097/MOH.0000000000000225, ISSN: 1531-7048.

Guo Y, Bosompem A, Mohan S, Erdogan B, Ye F, Vickers KC, Sheng Q, Zhao S, Li CI, Su PF, Jagasia M, Strickland SA, Griffiths EA, Kim AS. Transfer RNA detection by small RNA deep sequencing and disease association with myelodysplastic syndromes. BMC Genomics. 2015 Sep 9/24/2015; 16: 727. PMID: 26400237, PMCID: PMC4581457, PII: 10.1186/s12864-015-1929-y, DOI: 10.1186/s12864-015-1929-y, ISSN: 1471-2164.

Ravandi F, Ritchie EK, Sayar H, Lancet JE, Craig MD, Vey N, Strickland SA, Schiller GJ, Jabbour E, Erba HP, Pigneux A, Horst HA, Recher C, Klimek VM, Cortes J, Roboz GJ, Odenike O, Thomas X, Havelange V, Maertens J, Derigs HG, Heuser M, Damon L, Powell BL, Gaidano G, Carella AM, Wei A, Hogge D, Craig AR, Fox JA, Ward R, Smith JA, Acton G, Mehta C, Stuart RK, Kantarjian HM. Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, double-blind, multinational, phase 3 study. Lancet Oncol [print-electronic]. 2015 Sep; 16(9): 1025-36. PMID: 26234174, PMCID: PMC4822512, PII: S1470-2045(15)00201-6, DOI: 10.1016/S1470-2045(15)00201-6, ISSN: 1474-5488.

Zeidner JF, Foster MC, Blackford AL, Litzow MR, Morris LE, Strickland SA, Lancet JE, Bose P, Levy MY, Tibes R, Gojo I, Gocke CD, Rosner GL, Little RF, Wright JJ, Doyle LA, Smith BD, Karp JE. Randomized multicenter phase II study of flavopiridol (alvocidib), cytarabine, and mitoxantrone (FLAM) versus cytarabine/daunorubicin (7+3) in newly diagnosed acute myeloid leukemia. Haematologica [print-electronic]. 2015 Sep; 100(9): 1172-9. PMID: 26022709, PMCID: PMC4800702, PII: haematol.2015.125849, DOI: 10.3324/haematol.2015.125849, ISSN: 1592-8721.

Goswami M, Hensel N, Smith BD, Prince GT, Qin L, Levitsky HI, Strickland SA, Jagasia M, Savani BN, Fraser JW, Sadrzadeh H, Rajkhowa T, Ito S, Jain NA, Battiwalla M, Fathi AT, Levis MJ, Barrett AJ, Hourigan CS. Expression of putative targets of immunotherapy in acute myeloid leukemia and healthy tissues [letter]. Leukemia [print-electronic]. 2014 May; 28(5): 1167-70. PMID: 24472813, PMCID: PMC4013200, PII: leu201414, DOI: 10.1038/leu.2014.14, ISSN: 1476-5551.

Seegmiller AC, Kim AS, Mosse CA, Levy MA, Thompson MA, Kressin MK, Jagasia MH, Strickland SA, Reddy NM, Marx ER, Sinkfield KJ, Pollard HN, Plummer WD, Dupont WD, Shultz EK, Dittus RS, Stead WW, Santoro SA, Zutter MM. Optimizing personalized bone marrow testing using an evidence-based, interdisciplinary team approach. Am. J. Clin. Pathol. 2013 Nov; 140(5): 643-50. PMID: 24124142, PMCID: PMC4159763, PII: 140/5/643, DOI: 10.1309/AJCP8CKE9NEINQFL, ISSN: 1943-7722.

Strickland SA, Raptis A, Hallquist A, Rutledge J, Chernick M, Perree M, Talbott MS, Presant CA. Correlation of the microculture-kinetic drug-induced apoptosis assay with patient outcomes in initial treatment of adult acute myelocytic leukemia. Leuk. Lymphoma [print-electronic]. 2013 Mar; 54(3): 528-34. PMID: 22924433, DOI: 10.3109/10428194.2012.722217, ISSN: 1029-2403.

Sengsayadeth SM, Jagasia M, Engelhardt BG, Kassim A, Strickland SA, Goodman S, Lucid C, Vnencak-Jones CL, Greer JP, Savani BN. Allo-SCT for high-risk AML-CR1 in the molecular era: impact of FLT3/ITD outweighs the conventional markers. Bone Marrow Transplant [print-electronic]. 2012 Dec; 47(12): 1535-7. PMID: 22659680, PII: bmt201288, DOI: 10.1038/bmt.2012.88, ISSN: 1476-5365.

Strickland SA, Berlin JD. Hiccups: underappreciated and underrecognized. J Support Oncol. 2009 Jul; 7(4): 128-9. PMID: 19731576, ISSN: 1544-6794.